Back
Smith & Nephew PLC Vs. Biodexa Pharmaceuticals PLC Industry Stock Comparison
Sell
34
SNN
Smith & Nephew PLC
Last Price:
25.12
Seasonality Move:
8.72%
Sell
20
BDRX
Biodexa Pharmaceuticals PLC
Last Price:
4.36
Seasonality Move:
-24.92%
Sell
34
Smith & Nephew PLC (SNN)
is a Sell
Is Smith & Nephew PLC a Buy, Sell or Hold?
- The current Smith & Nephew PLC [SNN] share price is $25.21. The Score for SNN is 34, which is 32% below its historic median score of 50, and infers higher risk than normal.
- SNN is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
20
Biodexa Pharmaceuticals PLC (BDRX)
is a Sell
Is Biodexa Pharmaceuticals PLC a Buy, Sell or Hold?
- The current Biodexa Pharmaceuticals PLC [BDRX] share price is $3.85. The Score for BDRX is 20, which is 60% below its historic median score of 50, and infers higher risk than normal.
- BDRX is currently trading in the 10-20% percentile range relative to its historical Stock Score levels.
- This Score is currently showing an extreme reading that indicates risk could be especially high.
SNN Stock Price Chart
What is Smith & Nephew PLC's stock price today?
-
The Smith & Nephew PLC share price today is $25.21
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and SNN is experiencing buying pressure, which is a positive indicator for future bullish movement.
BDRX Stock Price Chart
What is Biodexa Pharmaceuticals PLC's stock price today?
-
The Biodexa Pharmaceuticals PLC share price today is $3.85
The current trend is relatively stagnant and BDRX is experiencing buying pressure, which is a positive indicator for future bullish movement.
SNN Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -1.01 | Sell |
| Relative Strength Index (14 RSI): | 37.45 | Sell |
| Chaikin Money Flow: | 472994 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (24.55 - 28.67) | Sell |
| Bollinger Bands (100): | (26.71 - 31.01) | Sell |
BDRX Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.19 | Sell |
| Relative Strength Index (14 RSI): | 32.05 | Sell |
| Chaikin Money Flow: | 33020 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (4.49 - 6.73) | Sell |
| Bollinger Bands (100): | (-0.14 - 4.7) | Buy |
SNN Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 24.97 | Buy |
| 20-day SMA: | 25.94 | Sell |
| 50-day SMA: | 28.41 | Sell |
| 200-day SMA: | 27.35 | Sell |
| 8-day EMA: | 25.18 | Buy |
| 20-day EMA: | 25.94 | Sell |
| 50-day EMA: | 27.47 | Sell |
| 200-day EMA: | 27.72 | Sell |
BDRX Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 4.32 | Sell |
| 20-day SMA: | 5.34 | Sell |
| 50-day SMA: | 3.88 | Sell |
| 200-day SMA: | 1.72 | Buy |
| 8-day EMA: | 4.26 | Sell |
| 20-day EMA: | 4.78 | Sell |
| 50-day EMA: | 4.09 | Sell |
| 200-day EMA: | 12.29 | Sell |
Smith & Nephew PLC Earnings Growth & SNN Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.28 per share, and an increase next year of $0.30 per share.
Biodexa Pharmaceuticals PLC Earnings Growth & BDRX Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.09 per share, and an increase next year of $0.05 per share.
Smith & Nephew PLC Technical Analysis
| Nov 7 | Nov 8 | Nov 11 | Nov 12 | Nov 13 | Nov 14 | Nov 15 | Nov 18 | Nov 19 | Nov 20 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov | ||||||||||
| 07 | 08 | 11 | 12 | 13 | 14 | 15 | 18 | 19 | 20 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Biodexa Pharmaceuticals PLC Technical Analysis
| Nov 7 | Nov 8 | Nov 11 | Nov 12 | Nov 13 | Nov 14 | Nov 15 | Nov 18 | Nov 19 | Nov 20 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov | ||||||||||
| 07 | 08 | 11 | 12 | 13 | 14 | 15 | 18 | 19 | 20 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||